Immunization update and hot topics in clinical immunology: How does this relate to my practice?

Allergy and Asthma Proceedings

Volumn 27, Issue 6, 2006, Pages 454-464

  Bellanti, Joseph A ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

HUMAN; IMMUNOLOGY; MASS IMMUNIZATION; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; REVIEW;

HUMANS; MASS IMMUNIZATION; PHYSICIAN'S ROLE; VACCINES;

EID: 33845504901     PISSN: 10885412     EISSN: None     Source Type: Journal    
DOI: 10.2500/aap.2006.27.2896     Document Type: Review

References (28)

1. Bellanti JA, Zeligs BJ, Mendez de Inocencio J, et al. Alternative routes of immunization for prevention of infectious diseases: A new paradigm for the 21st century. Allergy Asthma Proc 22: 173-176, 2001.
2. Sabin AB. Measles, killer of millions in developing countries: Strategy for rapid elimination and continuing control. Eur J Epidemiol 7:1-22, 1991.
3. Rapaport HG. Clemens von Pirquet and allergy. Ann Allergy 31:467-475, 1973.
4. Bellanti JA, Sabra A, and Zeligs BJ. Gastrointestinal immunopathology and food allergy. Ann Allergy Asthma Immunol 93:26-32, 2004.
5. Cutts FT, Clements CJ, and Bennett JV. Alternative routes of measles immunization: A review. Biologicals 25:323-338, 1997.
6. Glezen WP. Control of influenza. Tex Heart Inst J 31:39-41, 2004.
7. Sabin AB, Flores Arechiga A, Fernandez de Castro J, et al. Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines. JAMA 249:2651-2662, 1983.
8. Sabin AB, Flores Arechiga A, Fernandez de Castro J, et al. Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response. JAMA 251: 2363-2371, 1984.
9. Sepulveda-Amor J, Valdespino-Gomez JL, Garcia-Garcia Mde L, et al. A randomized trial demonstrating successful boosting responses following simultaneous aerosols of measles and rubella (MR) vaccines in school age children. Vaccine 20:2790-2795, 2002.
10. Bennett JV, Fernandez de Castro J, Valdespino-Gomez JL, et al. Aerosolized measles and measles-rubella vaccines induce better measles antibody booster responses than injected vaccines: Randomized trials in Mexican schoolchildren. Bull World Health Organ 80:806-812, 2002.
11. Castro JF, Bennett JV, Rincon HG, et al. Evaluation of immunogenicity and side effects of triple viral vaccine (MMR) in adults, given by two routes: Subcutaneous and respiratory (aerosol). Vaccine 23:1079-1084, 2005.
12. Wong-Chew RM, Islas-Romero R, Garcia-Garcia MdeL, et al. Induction of cellular and humoral immunity after aerosol or subcutaneous administration of Edmonston-Zagreb measles vaccine as a primary dose to 12-month-old children. J Infect Dis 189:254-257, 2004.
13. Dilraj A, Cutts FT, de Castro JF, et al. Response to different measles vaccine strains given by aerosol and subcutaneous routes to schoolchildren: A randomised trial. Lancet 355:798-803, 2000.
14. Dilraj A, Cutts FT, Bennett JV, et al. Persistence of measles antibody two years after revaccination by aerosol or subcutaneous routes. Pediatr Infect Dis J. 19:1211-1213, 2000.
15. Bellanti JA, Zeligs BJ, Mendez-Inocencio J, et al. Immunologic studies of specific mucosal and systemic immune responses in Mexican school children after booster aerosol or subcutaneous immunization with measles vaccine. Vaccine 22:1214-1220, 2004.
16. Campion EW. Suspicions about the safety of vaccines. N Engl J Med 347:1474-1475, 2002.
17. Wakefield AJ, Murch SH, Anthony A, et al. Ileal-lymphoidnodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637-641, 1998.
18. Madsen KM, Hviid A, Vestergaard M, et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med 347:1477-1482, 2002.
19. Danzig L. Meningococcal vaccines. Pediatr Infect Dis J 23:285-292, 2004.
20. Rappuoli R. Reverse vaccinology, a genome-based approach to vaccine development. Vaccine 19:2688-2691, 2001.
21. Rappuoli R, and Covacci A. Reverse vaccinology and genomics. Science 302:602, 2003.
22. Capecchi B, Serruto D, Adu-Bobie J, et al. The genome revolution in vaccine research. Curr Issues Mol Biol 6:17-27, 2004.
23. Mutsch M, Zhou W, Rhodes P, et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland. N Engl J Med 350:896-903, 2004.
24. Openshaw PJ, Yamaguchi Y, and Tregoning JS. Childhood infections, the developing immune system, and the origins of asthma. J Allergy Clin Immunol 114:1275-1277, 2004.
25. Martinez FD. Respiratory syncytial virus bronchiolitis and the pathogenesis of childhood asthma. Pediatr Infect Dis J 22(suppl 2):S76-S82, 2003.
26. Guilbert TW, Morgan WJ, Zeiger RS, et al. Atopic characteristics of children with recurrent wheezing at high risk for the development of childhood asthma. J Allergy Clin Immunol 114:1282-1287, 2004.
27. Bergen R, Black S, Shinefield H, et al. Safety of cold-adapted live attenuated influenza vaccine in a large cohort of children and adolescents. Pediatr Infect Dis J 23:138-144, 2004.
28. Centers for Disease Control and Prevention (CDC). Influenza and pneumococcal vaccination coverage among persons aged > or =65 years and persons aged 18-64 years with diabetes or asthma-United States, 2003. MMWR Morb Mortal Wkly Rep 53:1007-1012, 2004.